An emerging IVD superpower-Vector Biotek

Corporate diagnostic culture is all about day-to-day transformation. This transformation is the Rise of Phoenix, a perfect metaphor of growth in the corporate world. Mergers and acquisitions are also one of the factors that can be significant for accomplishing corporate growth trends.

Vector Biotek which has meaning of the measurement with both size and direction has always provided IVD automation solutions, which incorporates quality of products and services for clinical laboratories to offer reliable diagnosis since the time of its inception.

As a pioneer in IVD industry at Vector Biotek which is a flagship company of Beacon Group, we have been very detailed about our marketing strategies. We recognize the need of our customers thoroughly and provide the products of the first-rate quality with on time service support. This helps us in creating a Brand Image, so we can proudly convey to our customers that think laboratory automation – think Vector.

At Beacon Group our core competency is manufacturing of wide varieties of IVD reagents, and we started our operation with this core strength. This has been the fundamental reason for our quick success in the initial phase, since during the time we started the operations, the Indian IVD market was mostly dominated by the MNC players and in that complex and competitive situation Beacon Group made a way for Indian entrepreneurs to venture into this business. Once we establish as basic manufacturer for IVD reagents we then take look at the other areas of IVD business and diversifying from that fundamental strength and establishing our business successfully in hematology automation were the biggest conquering moments for us in the early stage of operation at Vector. This was then followed by offering many such innovative & time-tested automation products in segments like clinical chemistry, immunoassay, electrolyte, POCT, and HPLC.

IVD market is one of the most dynamic marketplaces. As a traditional player in this market, we are always optimistic to offer new products and technologies keeping in view the customer delight through offering of better quality of products and timely services. Our corporate vision is always to find better ways to avail this and we believe merger and acquisitions could also be one of the ways to achieve this landmark.

With the vision of building excellence, the possible future M&A will revolve around enhancing our product quality, which according to us means offering of the products that can be easy to use, requiring less maintenance and giving accuracy and precision of the results which are core requirements for IVD products.

In addition to the product quality, marketing strategies, technical competency for our staff are also equally important aspects of business.

As corporate philosophy which directs our endeavors towards continuous improvements, we Beaconians evolve constantly as provider of leading global brands, through persistent innovation and customer centric approach.

The premium benchmark for success in IVD business is consistency in offering reliable quality of products and timely availability of service, we take microlevel analysis of all of our day to day activities to fulfil these inevitable needs. At the same time by using the emerging replications we add dynamism in our activities.

We are sturdy to the inclusion of merger and acquirer constant consequences with many manage variables and to numerous different sensitivity tests. Since M&A performances had been debatable, we are greatly open in the direction of making joint plans which can enhance customer reach, and product performance that can best match with requirements of our valued customers.

Moreover, the world is already facing greater volatility in financial markets, further disruptions in global supply chain and increased levels of fiscal debts, as shockwaves from the pandemic. We have understood these adverse traits and as a result, we stay alert to how the new accelerated pace of change can bring these adversities in control.

We are open to M&A based on technological capabilities and transform the IVD business module worldwide to match our corporate philosophy of providing best IVD solutions with excellent quality of products and services for clinical laboratories.